Volume 11 (2013): Issue 2 (Feb 2013)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxvi–xxvii
Oncology Research Program
Pages: xxviii
NCCN's Value Pathways: The Drive for Quality Cancer Care
By: Patricia J. Goldsmith
Pages: 119–120
Defining Cancer Care Quality or Delivering Quality Cancer Care?
By: Matt Brow, J. Russell Hoverman, Debra Patt, Bill Herman, Diana Verrilli, Jody Garey, and Roy Beveridge
Pages: 121–124
Ten Years of Progress Against Breast Cancer: A Partnership of Basic and Clinical/Translational Science
By: Robert W. Carlson and on behalf of the NCCN Breast Cancer Panel
Pages: 132–136
Brentuximab in the Treatment of CD30-Positive Enteropathy-Associated T-Cell Lymphoma
By: Waleed F. Khalaf, Meghan E. Caldwell, and Nishitha Reddy
Pages: 137–140
Metastatic Colon Cancer, Version 3.2013
Featured Updates to the NCCN Guidelines
By: Al B. Benson III, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Moon J. Fenton, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Ahmed Kamel, Lucille A. Leong, Edward Lin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Kristina M. Gregory, and Deborah A. Freedman-Cass
Pages: 141–152
Local Therapies for Hepatic Metastases
By: Fabian M. Johnston, Michael N. Mavros, Joseph M. Herman, and Timothy M. Pawlik
Pages: 153–160
Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancers
By: Helena A. Yu and Gregory J. Riely
Pages: 161–169
Using Multigene Tests to Select Treatment for Early-Stage Breast Cancer
By: Rodrigo Goncalves and Ron Bose
Pages: 174–182
The Role of Active Surveillance in the Management of Prostate Cancer
By: Simon D. Fung-Kee-Fung, Sima P. Porten, Maxwell V. Meng, and Michael Kuettel
Pages: 183–187
Distress Management
By: Jimmie C. Holland, Barbara Andersen, William S. Breitbart, Luke O. Buchmann, Bruce Compas, Teresa L. Deshields, Moreen M. Dudley, Stewart Fleishman, Caryl D. Fulcher, Donna B. Greenberg, Carl B. Greiner, Rev. George F. Handzo, Laura Hoofring, Charles Hoover, Paul B. Jacobsen, Elizabeth Kvale, Michael H. Levy, Matthew J. Loscalzo, Randi McAllister-Black, Karen Y. Mechanic, Oxana Palesh, Janice P. Pazar, Michelle B. Riba, Kristin Roper, Alan D. Valentine, Lynne I. Wagner, Michael A. Zevon, Nicole R. McMillian, and Deborah A. Freedman-Cass
Pages: 190–209
Using the Science of Psychosocial Care to Implement the New American College of Surgeons Commission on Cancer Distress Screening Standard
By: Lynne I. Wagner, David Spiegel, and Timothy Pearman
Pages: 214–221
Progress in the Implementation of NCCN Guidelines for Distress Management by Member Institutions
By: Kristine A. Donovan and Paul B. Jacobsen
Pages: 223–226
An Update on NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations: Year 3
By: Elizabeth Danielson
Pages: 227–228
  • Collapse
  • Expand